Consequences of canceling elective invasive cardiac procedures during Covid-19 outbreak.
catheterization
diagnostic
percutaneous coronary intervention (PCI)
transcatheter valve implantation (TVI)
Journal
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
ISSN: 1522-726X
Titre abrégé: Catheter Cardiovasc Interv
Pays: United States
ID NLM: 100884139
Informations de publication
Date de publication:
01 04 2021
01 04 2021
Historique:
revised:
16
11
2020
received:
05
10
2020
accepted:
29
11
2020
pubmed:
19
12
2020
medline:
28
4
2021
entrez:
18
12
2020
Statut:
ppublish
Résumé
During COVID-19 pandemic in Spain, elective procedures were canceled or postponed, mainly due to health care systems overwhelming. The objective of this study was to evaluate the consequences of interrupting invasive procedures in patients with chronic cardiac diseases due to the COVID-19 outbreak in Spain. The study population is comprised of 2,158 patients that were pending on elective cardiac invasive procedures in 37 hospitals in Spain on the 14th of March 2020, when a state of alarm and subsequent lockdown was declared in Spain due to the COVID-19 pandemic. These patients were followed-up until April 31th. Out of the 2,158 patients, 36 (1.7%) died. Mortality was significantly higher in patients pending on structural procedures (4.5% vs. 0.8%, respectively; p < .001), in those >80 year-old (5.1% vs. 0.7%, p < .001), and in presence of diabetes (2.7% vs. 0.9%, p = .001), hypertension (2.0% vs. 0.6%, p = .014), hypercholesterolemia (2.0% vs. 0.9%, p = .026) [Correction added on December 23, 2020, after first online publication: as per Dr. Moreno's request changes in p-values were made after original publication in Abstract.], chronic renal failure (6.0% vs. 1.2%, p < .001), NYHA > II (3.8% vs. 1.2%, p = .001), and CCS > II (4.2% vs. 1.4%, p = .013), whereas was it was significantly lower in smokers (0.5% vs. 1.9%, p = .013). Multivariable analysis identified age > 80, diabetes, renal failure and CCS > II as independent predictors for mortality. Mortality at 45 days during COVID-19 outbreak in patients with chronic cardiovascular diseases included in a waiting list due to cancellation of invasive elective procedures was 1.7%. Some clinical characteristics may be of help in patient selection for being promptly treated when similar situations happen in the future.
Sections du résumé
BACKGROUND
During COVID-19 pandemic in Spain, elective procedures were canceled or postponed, mainly due to health care systems overwhelming.
OBJECTIVE
The objective of this study was to evaluate the consequences of interrupting invasive procedures in patients with chronic cardiac diseases due to the COVID-19 outbreak in Spain.
METHODS
The study population is comprised of 2,158 patients that were pending on elective cardiac invasive procedures in 37 hospitals in Spain on the 14th of March 2020, when a state of alarm and subsequent lockdown was declared in Spain due to the COVID-19 pandemic. These patients were followed-up until April 31th.
RESULTS
Out of the 2,158 patients, 36 (1.7%) died. Mortality was significantly higher in patients pending on structural procedures (4.5% vs. 0.8%, respectively; p < .001), in those >80 year-old (5.1% vs. 0.7%, p < .001), and in presence of diabetes (2.7% vs. 0.9%, p = .001), hypertension (2.0% vs. 0.6%, p = .014), hypercholesterolemia (2.0% vs. 0.9%, p = .026) [Correction added on December 23, 2020, after first online publication: as per Dr. Moreno's request changes in p-values were made after original publication in Abstract.], chronic renal failure (6.0% vs. 1.2%, p < .001), NYHA > II (3.8% vs. 1.2%, p = .001), and CCS > II (4.2% vs. 1.4%, p = .013), whereas was it was significantly lower in smokers (0.5% vs. 1.9%, p = .013). Multivariable analysis identified age > 80, diabetes, renal failure and CCS > II as independent predictors for mortality.
CONCLUSION
Mortality at 45 days during COVID-19 outbreak in patients with chronic cardiovascular diseases included in a waiting list due to cancellation of invasive elective procedures was 1.7%. Some clinical characteristics may be of help in patient selection for being promptly treated when similar situations happen in the future.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
927-937Informations de copyright
© 2020 Wiley Periodicals LLC.
Références
World Health Organization. Coronavirus disease 2019 (COVID-19) situation report - 78. Geneva: WHO; 2020.
Johns Hopkins Coronavirus Resource Center. Johns Hopkins Coronavirus Resource Center; 2020. https://coronavirus.jhu.edu/https://www.gouvernement.fr/info-coronavirus/carte-et-donnees.
Romaguera R, Cruz-González I, Jurado-Román A, et al. Considerations on the invasive management of ischemic and structural heart disease during the COVID-19 coronavirus outbreak. Consensus statement of the interventional cardiology association and the ischemic heart disease and acute cardiac Care Association of the Spanish Society of cardiology. REC Interv Cardiol. 2020;2:106-111.
Moreno R, Ojeda S, Romaguera R, Jimenez-Quevedo P, Cruz-González I. Transcatheter aortic valve replacement during COVID-19 pandemic. Recommendations from the Association of Interventional Cardiology of the Spanish Society of Cardiology (ACI-SEC). REC: Interv Cardiol. 2020;2:230-231.
Rodríguez-Leor O, Cid-Álvarez B, Ojeda S, et al. Impact of the COVID-19 pandemic on interventional cardiology activity in Spain. REC: Interv Cardiol. 2020;2:82-89.
Real Decreto 463/2020, de 14 de marzo, por el que se declara el estado de alarma para la gestión de la situación de crisis sanitaria ocasionada por el COVID-19. BOE núm. 67, de 14 de marzo de 2020, páginas 25390 a 25400. https://www.boe.es/eli/es/rd/2020/03/14/463.
Mourey L, Falandry C, de Decker L, Boulahssass R, Carola E, Bengrine Lefevre L. Taking care of older patients with cancer in the context of COVID-19 pandemic. Lancet Oncol. 2020;21(5):e236.
SEC Working Group for the 2019 ESC guidelines on chronic coronary syndromes, Expert Reviewers for the 2019 ESC guidelines on chronic coronary syndromes, SEC Guidelines Committe; SEC Working Group for the 2019 ESC guidelines on chronic coronary syndromes; SEC Guidelines Committee. Comments on the 2019 ESC guidelines on chronic coronary syndromes. Rev Esp Cardiol. 2020;73:439-444.
Otto CM. Informed shared decisions for patients with aortic stenosis. N Engl J Med. 2019;380:1769-1770.
Moreno R, Alonso JJ, Caballero R, et al. Influence of age and gender on arrival of patients with ST-segment elevation acute myocardial infarction to tertiary centers during COVID-19 pandemic. Experience of Madrid, Spain, STEMI network (Codigo Infarto Madrid). Am J Emerg Med. 2020. https://doi.org/10.1016/j.ajem.2020.06.013. [Epub ahead of print].
Elbaz-Greener G, Mashi S, Fnag J, et al. Temporal trends and clinical consequences of wait times for transcatheter aortic valve replacement. A population-based study. Circulation. 2018;138:483-493.
Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597-1607.
Obadia JF, Messika-Zeitoun D, Leurent G, et al. Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med. 2018;379:2297-2306.
Stone GW, Lindenfeld J, Abraham WT, et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med. 2018;379:2307-2231.
Talwar S, Karpha M, Thomas R, et al. Disease progression and adverse events in patients listed for elective percutaneous coronary intervention. Postgrad Med J. 2005;81:459-462.
Head SJ, da Costa BR, Beumer B, et al. Adverse events while awaiting myocardial revascularization: a systematic review and meta-analysis. Eur J Cardiothorac Surg. 2017;52:206-217.
Maron DJ, Hochman JS, Reynolds HR, et al. Initial invasive or conservative strategy for stable coronary disease. N Engl J Med. 2020;382:1395-1407.
Norhammar A, Malmberg K, Diderholm E, et al. Diabetes mellitus: the major risk factor in unstable CAD even after consideration of the extent of CAD and benefits of revascularization. J Am Coll Cardiol. 2004;43:585-591.
Moreno R, Lopez de Sa E, Lopez-Sendon JL, et al. Prognosis of medically stabilized unstable angina pectoris with a negative exercise test. Am J Cardiol. 1998;82:662-665.
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C-Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296-1305.
Pellikka PA, Sarano ME, Nishimura RA, et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation. 2005;111:3290-3295.
Gao Q, Hu Y, Dai Z, Xiao F, Wang J, Wu J. The epidemiological characteristics of 2019 novel coronavirus diseases (COVID-19) in Jingmen, Hubei, China. Medicine (Baltimore). 2020;99(23):e20605.
Suleyman G, Fadel RA, Malette KM, et al. Clinical characteristics and morbidity associated with coronavirus disease 2019 in a series of patients in metropolitan Detroit. JAMA Netw Open. 2020;3(6):e2012270.
Chung CJ, Nazif TM, Wolbinski M, et al. The restructuring of structural heart disease practice during the Covid-19 pandemic. J Am Coll Cardiol. 2020;75:2974-2983.
Shah PB, Welt FGP, Mahmud E, et al. Triage considerations for patients referred for structural heart disease intervention during the coronavirus disease 2019 (COVID-19) pandemic: an ACC /SCAI consensus statement. JACC Cardiovasc Interv. 2020;13:1484-1488.